Willoughby Scott B. (CIK 1877368) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-26). Recent activity: Sell SGMO (1,650 shares), Sell SGMO (12,354 shares), Sell SGMO (36,676 shares), Sell SGMO (2,035 shares), Sell SGMO (44,122 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 1,650 | $776 |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 12,354 | $5,806 |
| 2026-01-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 36,676 | $14,670 |
| 2025-11-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 2,035 | $855 |
| 2025-10-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 44,122 | $29,121 |
| 2025-08-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 1,434 | $846 |
| 2025-07-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 31,866 | $15,296 |
| 2025-05-28 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, CHIEF LEGAL OFFICER, SECY | Sell | 1,433 | $674 |
| 2025-04-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, GEN. COUNSEL & SECRETARY | Sell | 31,866 | $24,855 |
| 2025-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, GEN. COUNSEL & SECRETARY | Sell | 1,434 | $1,434 |
| 2025-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, GEN. COUNSEL & SECRETARY | Sell | 1,375 | $1,320 |
| 2025-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, GEN. COUNSEL & SECRETARY | Buy | 120,000 | $0 |
| 2025-01-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP, GEN. COUNSEL & SECRETARY | Sell | 129,549 | $148,981 |
Source: SEC Form 4 filings · as of 2026-02-26